AxoGen (AXGN)
(Real Time Quote from BATS)
$6.65 USD
+0.13 (1.99%)
Updated Apr 26, 2024 10:18 AM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Brokerage Reports
0 items in cart
AxoGen, Inc. [AXGN]
Reports for Purchase
Showing records 1 - 20 ( 71 total )
Company: AxoGen, Inc.
Industry: Medical - Instruments
Optimized Entry and Exit Levels for AXGN 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: AxoGen, Inc.
Industry: Medical - Instruments
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
We are dropping coverage of the following stocks
Provider: Roth Capital Partners, Inc.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Dropping Coverage due to reallocate our research resources.
Provider: Roth Capital Partners, Inc.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Medical Devices -Dropping Coverage Due to Analyst Departure
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Upbeat on New Breast Reconstruction Opportunity
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Another Quarter of Steady Outperformance
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Healthcare - Coverage Update - Healthcare Sector
Provider: Roth Capital Partners, Inc.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
We are placing shares of AXGN Under Review, and transferring coverage to Scott Henry, CFA due to the departure of the covering analyst.
Provider: Roth Capital Partners, Inc.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Medical Devices - 3Q17 Earnings Preview: Anti-climatic due to Seasonally Soft Qtr and Hurricanes
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
ASSH Meeting Showcases Reinvigorated Surgeon Interest in Nerve Repair
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Medical Devices - Healthcare Conference
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Another Quarter of Steady Outperformance
Provider: WEDBUSH SECURITIES INC.
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
Company: AxoGen, Inc.
Industry: Medical - Generic Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.